Stay updated on Magrolimab Combo in AML Clinical Trial
Sign up to get notified when there's something new on the Magrolimab Combo in AML Clinical Trial page.

Latest updates to the Magrolimab Combo in AML Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoNo Change Detected
- Check19 days agoChange DetectedRevision label updated from v3.6.4 to v3.6.5 for the page/document. This indicates a metadata/version update rather than changes to study content or functionality.SummaryDifference0.0%

- Check33 days agoChange DetectedRevision tag on the page updated from v3.6.3 to v3.6.4. This indicates a small metadata update to the page version.SummaryDifference0.0%

- Check54 days agoChange DetectedThe page now displays the updated revision tag, indicating a new release of the page template rather than any changes to the study details.SummaryDifference0.0%

- Check62 days agoChange DetectedThe page shows a newer revision number, replacing the previous one. This likely reflects an internal template or CMS update and does not indicate changes to the study content.SummaryDifference0.0%

- Check76 days agoChange DetectedNew user guidance sections were added and a recruitment status line indicates that enrollment has ended. The Intervention/Treatment header formatting was updated and a site revision note (Revision: v3.6.0) was added.SummaryDifference0.2%

- Check83 days agoChange DetectedPage revision updated from v3.5.4 to v3.5.5, signaling a new release of the page content.SummaryDifference0.0%

Stay in the know with updates to Magrolimab Combo in AML Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Magrolimab Combo in AML Clinical Trial page.